Nair Vinay’s Supernus Pharmaceuticals SUPN Stock Holding History

Nair Vinay’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-14,861	Closed	-$180K	–	321
2015 Q1	$180K	Buy	+14,861	New	+$140K	0.13%	332

Other funds holding SUPN

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MRM

Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

Nair Vinay's SUPN Position: Q2 2015 in Review

Nair Vinay sold out of Supernus Pharmaceuticals (SUPN) in Q2 2015, closing a stake of 14,861 shares — an estimated $180K sold.

Nair Vinay first reported a position in SUPN in Q1 2015 and held it in 1 quarter. The position peaked at $180K in Q1 2015. 166 funds tracked by Wall St. Rank hold SUPN as of Q2 2015.

Nair Vinay reported no remaining Supernus Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Nair Vinay sold 14,861 Supernus Pharmaceuticals shares in Q2 2015, an estimated $180K.
Nair Vinay first reported a position in Supernus Pharmaceuticals in Q1 2015 and held it in 1 quarter.
Nair Vinay's Supernus Pharmaceuticals position peaked at $180K in Q1 2015.
166 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2015.

Based on Nair Vinay's 13F filing for Q2 2015, filed 12 Aug 2015.